BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

42 hedge funds and large institutions have $17.1M invested in BRAINSTORM CELL THERAPUTC in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

13% less funds holding

Funds holding: 48 → 42 (-6)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.65M
Puts
$435K
Net Calls
Net Calls Change

Top Buyers

1
+$254K
2
+$194K
3
+$170K
4
Millennium Management
Millennium Management
New York
+$148K
5
Creative Planning
Creative Planning
Kansas
+$136K

Top Sellers

1
-$516K
2
-$280K
3
-$70K
4
Group One Trading
Group One Trading
Illinois
-$67K
5
VF
Virtu Financial
New York
-$57K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$51K
27
$50K
28
$48K
29
$46K
30
$36K
31
$33K
32
$23K
33
$18K
34
$13K
35
$11K
36
$7K
37
$7K
38
$1.61K
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
1
2